Overview
The Pharmacogenetics Core is responsible for correlating outcome observations (toxicity, efficacy, survival, PK/PD) with genetic variants (germline or somatic) to identify key genetic determinants and biomarkers that predict response to specific treatments. We also evaluate the impact of genetic variants on drug metabolism, transport, and molecular targets that influence drug resistance or contribute to inter-individual variation in therapeutic outcomes.
Contact Details
Facility Head: William Douglas Figg, Sr., Pharm.D.
Phone: 301.402.3622
Email: wdfigg@helix.nih.gov
Address: Building 10, Room 5A01, Bethesda
User Guidelines
The Pharmacogenetics Core is open to all NCI intramural clinical investigators.
Contact Information
Name:
figgw@mail.nih.gov
Title:
figgw@mail.nih.gov
Address:
9000 Rockville PikeBethesda, MD 20892
Phone:
E-Mail: